Literature DB >> 12202882

Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises.

Andrew M Atz1, Amy K Lefler, David L Fairbrother, Walter E Uber, Scott M Bradley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12202882     DOI： 10.1067/mtc.2002.125265

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  27 in total

Review 1.  Advances in pediatric pulmonary arterial hypertension.

Authors:  Dunbar Ivy
Journal:  Curr Opin Cardiol       Date:  2012-03       Impact factor: 2.161

Review 2.  Severe paediatric pulmonary hypertension: new management strategies.

Authors:  A Rashid; D Ivy
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

3.  Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.

Authors:  Jackie D Corbin; Roya Zoraghi; Sharron H Francis
Journal:  Cell Signal       Date:  2009-08-06       Impact factor: 4.315

4.  Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.

Authors:  Gaetano Palma; Raffaele Giordano; Veronica Russolillo; Sabato Cioffi; Sergio Palumbo; Marco Mucerino; Vincenzo Poli; Carlo Vosa
Journal:  Tex Heart Inst J       Date:  2011

Review 5.  Drug treatment of pulmonary hypertension in children.

Authors:  Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

6.  [Acute perioperative right heart insufficiency : Diagnostics and treatment].

Authors:  B Schäfer; C-A Greim
Journal:  Anaesthesist       Date:  2018-01       Impact factor: 1.041

7.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

Review 8.  Evolving management of pediatric pulmonary arterial hypertension: impact of phosphodiesterase inhibitors.

Authors:  Andrew James Wardle; Robert M R Tulloh
Journal:  Pediatr Cardiol       Date:  2012-12-19       Impact factor: 1.655

9.  Drug therapy: Sildenafil for post-operative pulmonary hypertension and Eisenmenger syndrome - A brief review of literature and survey of expert opinion.

Authors:  Balu Vaidyanathan
Journal:  Ann Pediatr Cardiol       Date:  2008-01

Review 10.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.